SB

Suhas Bhanudasrao Wadawalkar

Director Additional Director DIN 08295975
DIN 08295975 First appointment Dec 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Dec 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Suhas Bhanudasrao Wadawalkar

Data last updated:

Suhas Bhanudasrao Wadawalkar was an Additional Director at Ishaanav Nutraceuticals Private Limited (2018–2019). The company operates in Pharma.

DIN 08295975
Primary Designation Additional Director
Industry Pharma
First Appointment 07 Dec 2018

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director07 Dec 20182016₹21.09 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ishaanav Nutraceuticals Private Limited
Premium access

Shareholding and investment profile for Suhas Bhanudasrao Wadawalkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suhas Bhanudasrao Wadawalkar

Suhas Bhanudasrao Wadawalkar was first appointed on 07 Dec 2018 as Additional Director at Ishaanav Nutraceuticals Private Limited.

Suhas Bhanudasrao Wadawalkar held 1 earlier board appointment: Ishaanav Nutraceuticals Private Limited (Additional Director, 07 Dec 2018 to 09 Feb 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available